3 Geographic Atrophy Clinical Trials in Oakland, CA (2026)

Q: How do I join a clinical trial in Oakland?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Oakland research site will contact you.

Recruiting Geographic Atrophy Studies in Oakland

NCT06393374Recruiting

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

This is a randomized, open-label study comparing the efficacy and safety of adjuvant sacituzumab tirumotecan (MK-2870) in combination with pembrolizumab compared to treatment of physician's choice (TP...

Oakland, CAPHASE31,530 participantsMerck Sharp & Dohme LLC

View Study Details

NCT03126916Recruiting

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

This phase III trial studies iobenguane I-131 or lorlatinib and standard therapy in treating younger patients with newly-diagnosed high-risk neuroblastoma or ganglioneuroblastoma. Radioactive drugs, s...

Oakland, CAPHASE3750 participantsChildren's Oncology Group

View Study Details

NCT07437963Recruiting

Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse

This phase I/II trial studies the side effects and best dose of iberdomide when given together with chemoimmunotherapy drugs and to see how well it works in treating patients with neuroblastoma that h...

Oakland, CAPHASE176 participantsNational Cancer Institute (NCI)

View Study Details

About Geographic Atrophy Clinical Trials in Oakland

Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.

There are currently 3 geographic atrophy clinical trials recruiting participants in Oakland, CA. These studies are seeking a combined 2,356 participants. Research is being sponsored by Merck Sharp & Dohme LLC, Children's Oncology Group, National Cancer Institute (NCI). Clinical trial participation is free and participants receive study-related medical care at no cost.

Geographic Atrophy Clinical Trials in Oakland — FAQ

Are there geographic atrophy clinical trials in Oakland?

Yes, there are 3 geographic atrophy clinical trials currently recruiting in Oakland, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Oakland?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Oakland research site will contact you about next steps.

Are clinical trials in Oakland free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Oakland studies also compensate for your time and travel.

What geographic atrophy treatments are being tested?

The 3 active trials in Oakland are testing new therapies including novel drugs, biologics, and treatment approaches for geographic atrophy.

Data updated October 16, 2026 from ClinicalTrials.gov